PULS hires Fredrik Lindgren as Chief Business Officer

On July 1, 2018 Fredrik Lindgren will assume the position of Chief Business Officer (CBO) at PULS. In his new role Fredrik will work with strategic and operational business development of the PULS portfolio, as well as contribute with support to the development of the individual project companies.

Glactone Pharma receives funding from Swelife and Medtech4health

​Glactone Pharma, in collaboration with researchers from Karolinska Institutet and Lund University, has been awarded a SEK 1,000,000 (approx. USD 115,000) grant from Swelife and Medtech4health. Glactone Pharma’s project, STAT3 inhibition as immunotherapy for the treatment of prostate cancer, aims to investigate the mechanism behind the combination effect of STAT3 inhibition and immunotherapy.

Share this page


Read more about our Protection of your personal data.